Dicyclomine 10mg + Paracetamol 500mg Tablet Franchise in Ahmedabad

Antispasmodic & Pain Relief Tablet Supplier in Bangalore

Scotspas Plus Tablet Distributor in Hyderabad

Gastrointestinal Cramp Relief Franchise Opportunity in Jaipur

Dual-action Analgesic Tablet Stockist in Mumbai
Dicyclomine-Paracetamol Combination Export & Manufacturing in Chandigarh

Home/Products /dicyclomine-10mg-paracetamol-500mg-tablet

Scotspas Plus Tablet

Composition : Dicyclomine (10mg) + Paracetamol (500mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Scotspas Plus Tablet contains Dicyclomine 10mg + Paracetamol 500mg, a dual-action medicine designed to provide rapid relief from abdominal cramps, gastrointestinal spasms, and associated pain or fever. Dicyclomine relaxes smooth muscles of the gut, reducing cramping, while Paracetamol addresses pain and fever, ensuring comprehensive symptomatic relief.

This combination is widely used in managing irritable bowel syndrome, colic, dyspepsia, and other functional gastrointestinal disorders. Its synergistic effect allows patients to experience faster comfort and improved daily functionality, making it a preferred choice for clinicians in gastroenterology and general medicine.

For distributors, hospitals, and pharmacy suppliers, Scotspas Plus Tablet is a high-demand gastrointestinal care product, frequently prescribed in outpatient departments, hospital wards, and physiotherapy-assisted gastrointestinal therapy units. Its dual mechanism ensures steady market demand and repeat orders.

Including Scotspas Plus Tablet in your product range strengthens your gastrointestinal and analgesic therapy segment, offering strong opportunities in hospital procurement, retail pharmacy supply, export markets, and third-party manufacturing. Its clinically proven efficacy makes it a valuable addition for pharmaceutical distributors.

Read More

About the Product

Scotspas Plus Tablet contains Dicyclomine 10mg + Paracetamol 500mg, a dual-action medicine designed to provide rapid relief from abdominal cramps, gastrointestinal spasms, and associated pain or fever. Dicyclomine relaxes smooth muscles of the gut, reducing cramping, while Paracetamol addresses pain and fever, ensuring comprehensive symptomatic relief.

This combination is widely used in managing irritable bowel syndrome, colic, dyspepsia, and other functional gastrointestinal disorders. Its synergistic effect allows patients to experience faster comfort and improved daily functionality, making it a preferred choice for clinicians in gastroenterology and general medicine.

For distributors, hospitals, and pharmacy suppliers, Scotspas Plus Tablet is a high-demand gastrointestinal care product, frequently prescribed in outpatient departments, hospital wards, and physiotherapy-assisted gastrointestinal therapy units. Its dual mechanism ensures steady market demand and repeat orders.

Including Scotspas Plus Tablet in your product range strengthens your gastrointestinal and analgesic therapy segment, offering strong opportunities in hospital procurement, retail pharmacy supply, export markets, and third-party manufacturing. Its clinically proven efficacy makes it a valuable addition for pharmaceutical distributors.

Some patients may experience dry mouth, dizziness, nausea, or mild drowsiness. Rarely, allergic reactions, blurred vision, or constipation may occur.

It is indicated for the relief of abdominal cramps, irritable bowel syndrome (IBS), and pain associated with gastrointestinal spasms. The combination helps reduce discomfort, bloating, and mild fever related to gastrointestinal disturbances.

Use only under medical supervision. Avoid in patients with hypersensitivity to Dicyclomine, Paracetamol, or with severe gastrointestinal obstruction, glaucoma, or myasthenia gravis. Take as prescribed and do not exceed recommended doses.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation